MEIER RICHARD A — SEC insider filings

SEC reporting owner CIK 1227305. 18 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-12-01 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)Director10—3 legs · 8,946 sh · $715,59116
Intersect ENT, Inc. (XENT)EVP & Chief Financial Officer5——11
ACCURAY INC (ARAY)Director2——2
Rockley Photonics Holdings Ltd (RKLY)President & CFO1——2

Insider filings — MEIER RICHARD A

FiledFormIssuerReported transactionsSource
2026-10-073ACCURAY INC (ARAY)Holdings only — no transactions reportedEDGAR
2026-10-074ACCURAY INC (ARAY)Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-05-224BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 6,650 @ $0EDGAR
2024-06-044BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 6,600 @ $63.10 · Tax withholding (F): 5,451 @ $76.41 · Option exercise (M): 6,600 (derivative) @ $0EDGAR
2024-05-234BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 7,080 @ $0EDGAR
2024-01-234BIOMARIN PHARMACEUTICAL INC (BMRN)Gift (G): 3,000 @ $0EDGAR
2023-05-244BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,190 @ $0EDGAR
2023-05-174BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 8,500 @ $67.81 · Tax withholding (F): 6,137 @ $93.93 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2022-10-214Rockley Photonics Holdings Ltd (RKLY)Grant/award (A): 1,891,521 (derivative) @ $0 · Grant/award (A): 1,891,521 (derivative) @ $0EDGAR
2022-05-264BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 4,980 @ $0EDGAR
2022-05-164Intersect ENT, Inc. (XENT)Code (U): 57,230 @ $28.25 · Code (U): 65,759 @ $28.25 · Code (U): 40,607 @ $28.25 · Code (U): 34,000 (derivative) @ $28.25 · Code (U): 74,852 (derivative) @ $28.25EDGAR
2022-05-044BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 8,500 @ $37.46 · Sale (S): 3,860 @ $82.09 · Sale (S): 18 @ $82.11 · Option exercise (M): 8,500 (derivative) @ $0EDGAR
2022-02-044Intersect ENT, Inc. (XENT)Grant/award (A): 36,738 @ $0 · Tax withholding (F): 2,329 @ $27.31EDGAR
2021-12-014Intersect ENT, Inc. (XENT)Tax withholding (F): 6,346 @ $26.94EDGAR
2021-05-274BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 5,120 @ $0EDGAR
2021-05-074BIOMARIN PHARMACEUTICAL INC (BMRN)Option exercise (M): 15,000 @ $26.49 · Sale (S): 5,068 @ $78.38 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-02-034Intersect ENT, Inc. (XENT)Grant/award (A): 17,411 @ $0 · Grant/award (A): 34,000 (derivative) @ $0EDGAR
2020-12-014Intersect ENT, Inc. (XENT)Tax withholding (F): 6,349 @ $20.00EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1227305 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs